Morgoulis, Daria
Berenstein, Peter
Cazacu, Simona
Kazimirsky, Gila
Dori, Amir
Barnea, Eytan R.
Brodie, Chaya
Funding for this research was provided by:
BioIncept LLC; ADI Foundation, Israel, the William and Karen Davidson Fund, Hermelin Brain Tumor Center, MI, USA
Article History
Received: 14 June 2018
Revised: 7 December 2018
Accepted: 17 December 2018
First Online: 28 January 2019
Conflict of interest
: Eytan R. Barnea is the Chief Scientific Officer of BioIncept, LLC. Chaya Brodie received a grant from BioIncept, LLC. The other authors declare no conflict of interest.